Lifeward Ltd. ( LFWD ) Q3 2025 Earnings Call November 14, 2025 8:30 AM EST Company Participants Almog Adar - Chief Financial Officer William Grant - President, CEO & Director Conference Call Participants Yale Jen - Laidlaw & Company (UK) Ltd.
Lifeward Ltd. (NASDAQ:LFWD ) Q2 2025 Earnings Conference Call August 14, 2025 8:30 AM ET Company Participants Almog Adar - Chief Financial Officer William Mark Grant - President, CEO & Director Conference Call Participants Benjamin Charles Haynor - Lake Street Capital Markets, LLC, Research Division I-Eh Jen - Laidlaw & Company (UK) Ltd.
Lifeward (LFWD) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.5 per share a year ago.
| Health Care Technology Industry | Healthcare Sector | William Mark Grant CEO | XBER Exchange | IL0011331076 ISIN |
| IL Country | 80 Employees | - Last Dividend | 15 Mar 2024 Last Split | - IPO Date |
Lifeward Ltd. is a pioneering medical device company founded by Amit Goffer on June 20, 2001, with its headquarters based in Marlborough, MA. Specializing in the design, development, and marketing of wearable robotic exoskeletons, the company focuses on innovative solutions to enhance mobility for individuals suffering from spinal cord injuries (SCI). Lifeward Ltd.’s mission revolves around leveraging advanced technology to enable users to stand upright, walk, turn, and navigate stairs with ease, thereby improving their quality of life and fostering greater independence.